---
title: "[14] Transcription factor competition at the γ-globin promoters controls hemoglobin switching"
featured_title: "The Molecular Tug-of-War Behind Hemoglobin Switching"
authors: ["N Liu", "S Xu", "Q Yao", "Q Zhu", "me", "JY Hsu", "P Sakon", "L Pinello", "GC Yuan", "et al."]
date: "2021-04-01"
weight: 11
publication_types: ["article-journal"]
publication: "*Nature Genetics* 53 (4), 511-520"
featured: true
image:
  caption: 'Transcription Factor Competition'
  focal_point: ""
  preview_only: false
summary: "We uncovered a direct competition mechanism between BCL11A and other activators at the gamma-globin promoter, determining the developmental switch."
---

Hemoglobin switching involves the silencing of fetal gamma-globin genes and the activation of adult beta-globin genes. While BCL11A is known as the master repressor, the precise molecular mechanism of its action at the promoter level remained elusive.

By integrating high-resolution genomic data with thermodynamic modeling, we demonstrated a **transcription factor competition model**. We found that BCL11A does not merely sit on the DNA to block access; it actively competes with transcriptional activators (such as NF-Y and LRF) for binding to overlapping motifs at the CCAAT box region of the gamma-globin promoters.

Key findings include:
*   **Direct Competition**: The binding of BCL11A mutually excludes the binding of ubiquitous activators.
*   **Thermodynamic Control**: The outcome of the switch is determined by the relative concentrations and binding affinities of these competing factors.
*   **Therapeutic Implications**: Disrupting the BCL11A binding site tips the balance in favor of activators, leading to HbF re-induction—a strategy now utilized in gene therapies for Sickle Cell Disease and Beta-Thalassemia.

This study provides a mechanistic framework for understanding how repressor-activator interplay dictates cell fate decisions.
